The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $1.03 | $26K |
| Jun 30, 2026 | Evans John M. | CEO, Director | Sell(S) | 23K | $34.26 | $791K |
| Jun 30, 2026 | Evans John M. | CEO, Director | Sell(S) | 2K | $34.84 | $66K |
| Jun 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Jun 30, 2026 | Simon Amy | Chief Medical Officer | Sell(S) | 373 | $34.73 | $13K |
| Jun 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 19K | $0.67 | $13K |
| Jun 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 6K | $1.03 | $7K |
| Jun 29, 2026 | Evans John M. | CEO, Director | Sell(S) | 13K | $35.13 | $472K |
| Jun 29, 2026 | Evans John M. | CEO, Director | Sell(S) | 12K | $35.91 | $416K |
| Jun 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 19K | — | $0 |
| Jun 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 6K | — | $0 |
| Jun 26, 2026 | FMR LLC | 10% Owner | Sell(S) | 251K | $35.26 | $8.9M |
| Jun 25, 2026 | FMR LLC | 10% Owner | Sell(S) | 33K | $35.12 | $1.2M |
| Jun 17, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 7K | $0.67 | $4K |
| Jun 17, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 29K | $1.03 | $30K |
| Jun 17, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 7K | — | $0 |
| Jun 17, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 29K | — | $0 |
| Jun 3, 2026 | Shaw Christi | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2026 | Walsh Kathleen E | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2026 | Maraganore John | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2026 | Fishman Mark | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2026 | Guindo Chirfi | Director | Grant(A) | 20K | — | $0 |
| Jun 3, 2026 | Cooper Graham K | Director | Grant(A) | 20K | — | $0 |
| Apr 1, 2026 | Simon Amy | Chief Medical Officer | Sell(S) | 7K | $24.58 | $165K |
| Apr 1, 2026 | Evans John M. | CEO, Director | Sell(S) | 30K | $24.58 | $739K |
| Apr 1, 2026 | Ciaramella Giuseppe | President | Sell(S) | 12K | $24.58 | $290K |
| Apr 1, 2026 | Bellon Christine | Chief Legal Officer | Sell(S) | 6K | $24.58 | $146K |
| Apr 1, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 3K | $24.58 | $80K |
| Mar 31, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $0.67 | $17K |
| Mar 31, 2026 | Evans John M. | CEO, Director | Sell(S) | 25K | $22.76 | $569K |
| Mar 31, 2026 | Evans John M. | CEO, Director | Grant(A) | 90K | — | $0 |
| Mar 31, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Mar 31, 2026 | Ciaramella Giuseppe | President | Grant(A) | 40K | — | $0 |
| Mar 31, 2026 | Emany Sravan Kumar | Chief Financial Officer | Grant(A) | 32K | — | $0 |
| Mar 31, 2026 | Simon Amy | Chief Medical Officer | Grant(A) | 32K | — | $0 |
| Mar 31, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Grant(A) | 20K | — | $0 |
| Mar 31, 2026 | Bellon Christine | Chief Legal Officer | Grant(A) | 20K | — | $0 |
| Mar 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $0.67 | $17K |
| Mar 30, 2026 | Evans John M. | CEO, Director | Sell(S) | 25K | $22.37 | $559K |
| Mar 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Feb 24, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 35K | $17.00 | $595K |
| Feb 24, 2026 | Ciaramella Giuseppe | President | Sell(S) | 35K | $32.00 | $1.1M |
| Feb 24, 2026 | Ciaramella Giuseppe | President | Option exercise(M) | 35K | — | $0 |
| Jan 31, 2026 | Simon Amy | Chief Medical Officer | Grant(A) | 89K | — | $0 |
| Jan 31, 2026 | Evans John M. | CEO, Director | Grant(A) | 180K | — | $0 |
| Jan 31, 2026 | Bellon Christine | Chief Legal Officer | Grant(A) | 40K | — | $0 |
| Jan 31, 2026 | Emany Sravan Kumar | Chief Financial Officer | Grant(A) | 64K | — | $0 |
| Jan 31, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Grant(A) | 40K | — | $0 |
| Jan 31, 2026 | Ciaramella Giuseppe | President | Grant(A) | 80K | — | $0 |
| Jan 30, 2026 | Evans John M. | CEO, Director | Sell(S) | 3K | $29.00 | $84K |
| Jan 30, 2026 | Evans John M. | CEO, Director | Sell(S) | 22K | $28.27 | $625K |
| Jan 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $0.67 | $17K |
| Jan 30, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Jan 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 19K | $0.67 | $13K |
| Jan 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 6K | $0.67 | $4K |
| Jan 29, 2026 | Evans John M. | CEO, Director | Sell(S) | 16K | $29.19 | $477K |
| Jan 29, 2026 | Evans John M. | CEO, Director | Sell(S) | 9K | $29.74 | $258K |
| Jan 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 19K | — | $0 |
| Jan 29, 2026 | Evans John M. | CEO, Director | Option exercise(M) | 6K | — | $0 |
| Jan 22, 2026 | Bellon Christine | Chief Legal Officer | Sell(S) | 1K | $34.00 | $47K |
| Jan 22, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 6K | $35.00 | $217K |
| Jan 20, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 3K | $30.12 | $91K |
| Jan 15, 2026 | Bellon Christine | Chief Legal Officer | Sell(S) | 16K | $34.72 | $554K |
| Jan 15, 2026 | Bellon Christine | Chief Legal Officer | Sell(S) | 2K | $33.62 | $71K |
| Jan 15, 2026 | Bellon Christine | Chief Legal Officer | Sell(S) | 559 | $35.40 | $20K |
| Dec 31, 2025 | Simon Amy | Chief Medical Officer | Grant(A) | 13K | — | $0 |
| Dec 31, 2025 | Bellon Christine | Chief Legal Officer | Sell(S) | 1K | $27.10 | $34K |
| Dec 31, 2025 | Emany Sravan Kumar | Chief Financial Officer | Sell(S) | 6K | $27.10 | $171K |
| Oct 27, 2025 | FMR LLC | 10% Owner | Sell(S) | 459 | $26.68 | $12K |
| Oct 6, 2025 | FMR LLC | 10% Owner | Gift(G) | 1.2M | — | $0 |
| Oct 2, 2025 | Evans John M. | CEO, Director | Sell(S) | 25K | $24.63 | $616K |
| Oct 2, 2025 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $0.67 | $17K |
| Oct 2, 2025 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Oct 1, 2025 | Evans John M. | CEO, Director | Sell(S) | 25K | $24.51 | $613K |
| Oct 1, 2025 | Evans John M. | CEO, Director | Option exercise(M) | 25K | $0.67 | $17K |
| Oct 1, 2025 | Evans John M. | CEO, Director | Option exercise(M) | 25K | — | $0 |
| Oct 1, 2025 | Bellon Christine | Chief Legal Officer | Sell(S) | 373 | $24.53 | $9K |
| Oct 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 467 | $24.53 | $11K |
| Jul 30, 2025 | FMR LLC | 10% Owner | Sell(S) | 48K | $20.50 | $992K |
| Jul 3, 2025 | Simon Amy | Chief Medical Officer | Sell(S) | 876 | $20.12 | $18K |
| Jul 1, 2025 | Simon Amy | Chief Medical Officer | Sell(S) | 374 | $16.94 | $6K |
| Jun 4, 2025 | Cooper Graham K | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Ho Carole | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Guindo Chirfi | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Maraganore John | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Shaw Christi | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Fishman Mark | Director | Grant(A) | 34K | — | $0 |
| Jun 4, 2025 | Walsh Kathleen E | Director | Grant(A) | 34K | — | $0 |
| Apr 2, 2025 | Simon Amy | Chief Medical Officer | Sell(S) | 21K | $17.73 | $372K |
| Apr 1, 2025 | Simon Amy | Chief Medical Officer | Sell(S) | 10K | $18.35 | $176K |
| Apr 1, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 3K | $18.35 | $55K |
| Apr 1, 2025 | Ciaramella Giuseppe | President | Sell(S) | 7K | $18.35 | $136K |
| Apr 1, 2025 | Evans John M. | CEO, Director | Sell(S) | 31K | $18.35 | $563K |
| Apr 1, 2025 | Bellon Christine | Chief Legal Officer | Sell(S) | 6K | $18.35 | $104K |
| Mar 31, 2025 | Evans John M. | CEO, Director | Grant(A) | 78K | — | $0 |
| Mar 31, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Grant(A) | 10K | — | $0 |
| Mar 31, 2025 | Ciaramella Giuseppe | President | Grant(A) | 35K | — | $0 |
| Mar 31, 2025 | Simon Amy | Chief Medical Officer | Grant(A) | 28K | — | $0 |
| Mar 31, 2025 | Bellon Christine | Chief Legal Officer | Grant(A) | 20K | — | $0 |
| Feb 18, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell(S) | 6K | $35.00 | $220K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-21. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).